UNSPSC 51172815: Calcium carbonate/calcium phosphate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR200. This VA Drug Class (OR200) classifies this compound as belonging to the group DENTAL PROTECTANTS.

UNSPSC 51172815 Calcium carbonate/calcium phosphate is a Commodity code showing minimal recent state and local activity aligned with its nominal scope. The single identified recent opportunity—Minnesota's MMCAP Generic Multi Source Pharmaceuticals and OTC Products RFP (S1070000015802, due March 26, 2026)—targets generic pharmaceuticals and over-the-counter products distributed across participating state and local government facilities, with no explicit mention of calcium carbonate or calcium phosphate as line items. The procurement framework emphasizes National Drug Codes (NDC), SKUs, UPCs, and pricing through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), with evaluation weighted heavily toward price competitiveness (75 percent) and compliance with current Good Manufacturing Practices (cGMP) and Drug Supply Chain Security Act (DSCSA) certification. Vendors must maintain relationships with at least two of the three wholesalers, carry comprehensive insurance including $5 million commercial general liability coverage, and agree to a 3 percent administrative fee on all contract purchases. The contract term runs two years for new responders through June 30, 2028, with optional MMCAP extensions.

The opportunity originates from the Minnesota Department of Administration's Office of State Procurement administering the multistate MMCAP cooperative purchasing vehicle, with participating members including Oregon. The RFP imposes performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding timelines, or improper class-of-trade denials, and requires all products to possess FDA compliance and expiration dates of at least one year from manufacture with minimum six-month shelf life. Questions closed February 18, 2026, with awarded vendors to be provided to wholesalers by May 15, 2026 and resulting agreements effective July 1, 2026. No specific award values, budget ranges, or set-aside designations are disclosed in the available solicitation materials. The code shows no evidence of active procurement specifically for calcium carbonate or calcium phosphate products at this time.